eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | diffuse large b-cell lymphoma |
| Comorbidity | C0019158|hepatitis |
| Sentences | 6 |
| PubMedID- 22736295 | Clinical outcome of diffuse large b-cell lymphoma (dlbcl) patients with hepatitis c virus (hcv) infection in the rituximab era remains unclear. |
| PubMedID- 25848698 | We performed a retrospective study to analyse the characteristics and clinical outcomes of diffuse large b-cell lymphoma (dlbcl) patients with hepatitis b virus (hbv) infection and compare with those without hbv infection. |
| PubMedID- 23465418 | Early-stage splenic diffuse large b-cell lymphoma is highly associated with hepatitis c virus infection. |
| PubMedID- 26058465 | Conclusions: dlbcl patients with resolved hepatitis b may have a higher risk of developing hbv reactivation and hepatitis than hbsag-negative/hbcab-negative patients. |
| PubMedID- 25381127 | The notch pathway is recurrently mutated in diffuse large b-cell lymphoma associated with hepatitis c virus infection. |
| PubMedID- 24270404 | Outcome prediction of diffuse large b-cell lymphomas associated with hepatitis c virus infection: a study on behalf of the fondazione italiana linfomi. |
Page: 1